Zions Bancorporation’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $1.25M | Buy |
19,107
+6,775
| +55% | +$444K | 0.08% | 201 |
|
2024
Q3 | $961K | Buy |
12,332
+3,272
| +36% | +$255K | 0.07% | 204 |
|
2024
Q2 | $707K | Buy |
9,060
+7,301
| +415% | +$569K | 0.06% | 216 |
|
2024
Q1 | $119K | Sell |
1,759
-89
| -5% | -$6.03K | 0.01% | 353 |
|
2023
Q4 | $124K | Sell |
1,848
-27
| -1% | -$1.82K | 0.01% | 349 |
|
2023
Q3 | $127K | Sell |
1,875
-13
| -0.7% | -$880 | 0.01% | 331 |
|
2023
Q2 | $135K | Sell |
1,888
-2,431
| -56% | -$174K | 0.01% | 331 |
|
2023
Q1 | $300K | Sell |
4,319
-1,657
| -28% | -$115K | 0.03% | 278 |
|
2022
Q4 | $405K | Buy |
5,976
+652
| +12% | +$44.2K | 0.03% | 259 |
|
2022
Q3 | $292K | Buy |
5,324
+3,137
| +143% | +$172K | 0.03% | 275 |
|
2022
Q2 | $144K | Buy |
2,187
+48
| +2% | +$3.16K | 0.01% | 341 |
|
2022
Q1 | $142K | Buy |
2,139
+114
| +6% | +$7.57K | 0.01% | 368 |
|
2021
Q4 | $118K | Sell |
2,025
-12
| -0.6% | -$699 | 0.01% | 358 |
|
2021
Q3 | $122K | Sell |
2,037
-725
| -26% | -$43.4K | 0.01% | 345 |
|
2021
Q2 | $165K | Buy |
2,762
+190
| +7% | +$11.4K | 0.02% | 308 |
|
2021
Q1 | $128K | Sell |
2,572
-5,409
| -68% | -$269K | 0.01% | 318 |
|
2020
Q4 | $399K | Sell |
7,981
-284
| -3% | -$14.2K | 0.05% | 156 |
|
2020
Q3 | $453K | Buy |
8,265
+588
| +8% | +$32.2K | 0.06% | 123 |
|
2020
Q2 | $406K | Sell |
7,677
-1,042
| -12% | -$55.1K | 0.06% | 126 |
|
2020
Q1 | $389K | Buy |
8,719
+523
| +6% | +$23.3K | 0.07% | 108 |
|
2019
Q4 | $409K | Sell |
8,196
-1,176
| -13% | -$58.7K | 0.06% | 124 |
|
2019
Q3 | $418K | Buy |
+9,372
| New | +$418K | 0.06% | 131 |
|
2018
Q4 | – | Sell |
-21,215
| Closed | -$839K | – | 514 |
|
2018
Q3 | $839K | Buy |
+21,215
| New | +$839K | 0.2% | 66 |
|
2017
Q4 | – | Sell |
-38,852
| Closed | -$1.32M | – | 638 |
|
2017
Q3 | $1.32M | Buy |
38,852
+37,474
| +2,719% | +$1.27M | 0.19% | 74 |
|
2017
Q2 | $47K | Buy |
1,378
+39
| +3% | +$1.33K | 0.01% | 218 |
|
2017
Q1 | $43K | Sell |
1,339
-673
| -33% | -$21.6K | 0.01% | 205 |
|
2016
Q4 | $55K | Sell |
2,012
-812
| -29% | -$22.2K | 0.01% | 222 |
|
2016
Q3 | $91K | Buy |
2,824
+781
| +38% | +$25.2K | 0.02% | 171 |
|
2016
Q2 | $61K | Sell |
2,043
-782
| -28% | -$23.3K | 0.01% | 196 |
|
2016
Q1 | $82K | Sell |
2,825
-11
| -0.4% | -$319 | 0.01% | 181 |
|
2015
Q4 | $88K | Buy |
2,836
+90
| +3% | +$2.79K | 0.02% | 160 |
|
2015
Q3 | $87K | Buy |
2,746
+1,946
| +243% | +$61.7K | 0.02% | 154 |
|
2015
Q2 | $25K | Sell |
800
-2,128
| -73% | -$66.5K | ﹤0.01% | 200 |
|
2015
Q1 | $100K | Buy |
+2,928
| New | +$100K | 0.02% | 167 |
|